Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study (2022)
Attributed to:
ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.08.08.22278576
Publication URI: http://dx.doi.org/10.1101/2022.08.08.22278576
Type: Preprint